Android app on Google Play

WebMD (WBMD) Guidance 'Optimistic', Says Analyst

February 22, 2013 10:23 AM EST Send to a Friend
Get Alerts WBMD Hot Sheet
Price: $44.99 --0%

Rating Summary:
    5 Buy, 7 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 0 | Down: 0 | New: 0
Trade WBMD Now!
Join SI Premium – FREE
WebMD Health Corp. (NASDAQ: WBMD) stock opened higher on Friday after the company reported better than expected Q4 revenue and guidance that was well ahead of the Street. This prompted analysts at Stifel to upgrade WebMD to Buy. Others on Wall Street are not convinced, and think WebMD's guidance might be overly optimistic.

Analyst Heath P. Terry of Goldman Sachs is among the naysayers. She thinks, given the lack of viability, guidance "could prove optimistic".

"While revenue declines are moderating, we believe WebMD will continue to be negatively affected by a fundamental change in the online pharma advertising market, the shift in use from desktop to mobile and increasing competition," she concluded.

Goldman Sachs has a Sell rating on WebMD Health Corp. with a modified price target of $11.00 (from $10.00).

For an analyst ratings summary and ratings history on WebMD Health Corp. (NASDAQ: WBMD) click here. For more ratings news on WebMD Health Corp. click here.

Shares of WebMD Health Corp. closed at $16.30 yesterday.




You May Also Be Interested In


Related Categories

Analyst Comments, Analyst EPS View, Analyst PT Change

Related Entities

Goldman Sachs

Add Your Comment